247 related articles for article (PubMed ID: 27061136)
1. Elevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different?
Watson MM; Lea D; Rewcastle E; Hagland HR; Søreide K
Cancer Med; 2016 Jul; 5(7):1580-7. PubMed ID: 27061136
[TBL] [Abstract][Full Text] [Related]
2. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
[TBL] [Abstract][Full Text] [Related]
3. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
[TBL] [Abstract][Full Text] [Related]
4. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
[TBL] [Abstract][Full Text] [Related]
5. Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
Park Y; Kim DW; Hong YJ; Park KU; Nam SK; Na HY; Lee HS; Kim MH; Oh HK; Kang SB
J Surg Oncol; 2020 Dec; 122(7):1462-1469. PubMed ID: 32779222
[TBL] [Abstract][Full Text] [Related]
6. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.
Yamada K; Kanazawa S; Koike J; Sugiyama H; Xu C; Funahashi K; Boland CR; Koi M; Hemmi H
Oncol Rep; 2010 Feb; 23(2):551-61. PubMed ID: 20043121
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.
Watson MM; Lea D; Gudlaugsson E; Skaland I; Hagland HR; Søreide K
Cancer Immunol Immunother; 2020 Aug; 69(8):1627-1637. PubMed ID: 32314040
[TBL] [Abstract][Full Text] [Related]
9. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.
Burger M; Denzinger S; Hammerschmied CG; Tannapfel A; Obermann EC; Wieland WF; Hartmann A; Stoehr R
J Mol Med (Berl); 2006 Oct; 84(10):833-41. PubMed ID: 16924473
[TBL] [Abstract][Full Text] [Related]
10. EMAST status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for Stage II/III colorectal cancer.
Mohammadpour S; Goodarzi HR; Jafarinia M; Porhoseingholi MA; Nazemalhosseini-Mojarad E
J Cell Physiol; 2020 Apr; 235(4):3604-3611. PubMed ID: 31549400
[TBL] [Abstract][Full Text] [Related]
11. EMAST Type of Microsatellite Instability-A Distinct Entity or Blurred Overlap between Stable and MSI Tumors.
Vuković Đerfi K; Salar A; Cacev T; Kapitanović S
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510378
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of microsatellite instability in T1 colorectal cancer.
Kang J; Lee HW; Kim IK; Kim NK; Sohn SK; Lee KY
Yonsei Med J; 2015 Jan; 56(1):175-81. PubMed ID: 25510762
[TBL] [Abstract][Full Text] [Related]
13. EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.
Venderbosch S; van Lent-van Vliet S; de Haan AF; Ligtenberg MJ; Goossens M; Punt CJ; Koopman M; Nagtegaal ID
PLoS One; 2015; 10(4):e0124538. PubMed ID: 25884216
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia.
Lee SY; Miyai K; Han HS; Hwang DY; Seong MK; Chung H; Jung BH; Devaraj B; McGuire KL; Carethers JM
Dig Dis Sci; 2012 Jan; 57(1):72-8. PubMed ID: 21773681
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
[No Abstract] [Full Text] [Related]
16. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement.
Munakata K; Koi M; Kitajima T; Tseng-Rogenski S; Uemura M; Matsuno H; Kawai K; Sekido Y; Mizushima T; Toiyama Y; Yamada T; Mano M; Mita E; Kusunoki M; Mori M; Carethers JM
Clin Transl Gastroenterol; 2019 Dec; 10(12):e00105. PubMed ID: 31789935
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features.
Kazama Y; Watanabe T; Kanazawa T; Tanaka J; Tanaka T; Nagawa H
J Clin Pathol; 2007 Jun; 60(6):701-4. PubMed ID: 17557871
[TBL] [Abstract][Full Text] [Related]
18. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.
Haugen AC; Goel A; Yamada K; Marra G; Nguyen TP; Nagasaka T; Kanazawa S; Koike J; Kikuchi Y; Zhong X; Arita M; Shibuya K; Oshimura M; Hemmi H; Boland CR; Koi M
Cancer Res; 2008 Oct; 68(20):8465-72. PubMed ID: 18922920
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.
Hamaya Y; Guarinos C; Tseng-Rogenski SS; Iwaizumi M; Das R; Jover R; Castells A; Llor X; Andreu M; Carethers JM
PLoS One; 2015; 10(5):e0127591. PubMed ID: 25996601
[TBL] [Abstract][Full Text] [Related]
20. No evidence of EMAST in whole genome sequencing data from 248 colorectal cancers.
Kondelin J; Martin S; Katainen R; Renkonen-Sinisalo L; Lepistö A; Koskensalo S; Böhm J; Mecklin JP; Cajuso T; Hänninen UA; Välimäki N; Ravantti J; Rajamäki K; Palin K; Aaltonen LA
Genes Chromosomes Cancer; 2021 Jul; 60(7):463-473. PubMed ID: 33527622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]